Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current Views on Hepatitis C Virus Infection.

Epstein1, Knox

  • 1Gastroenterology Division, New England Medical Center Hospitals, Boston, MA USA.

Current Infectious Disease Reports
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malignant transformation of a giant congenital pigmented nevus (hamartoma) in a dog.

Veterinary dermatology·2021
Same author

Observations on the Anatomy of the Lacteal System in the Seal and Cetacea.

Edinburgh medical and surgical journal·2018
Same author

Physiological Observations on the Pulsations of the Heart, and on Its Diurnal Revolution and Excitability.

Edinburgh medical and surgical journal·2018
Same author

Remarks on the Lately Discovered Microscopic Entozoa, Infesting the Muscles of the Human Body; with Some Observations on a Similar Animal Found beneath the Intestinal Mucous Membrane of the Horse.

Edinburgh medical and surgical journal·2018
Same author

Contributions to Anatomy and Physiology.

Edinburgh medical and surgical journal·2018
Same author

Oscillatory clusters in a model of the photosensitive belousov-zhabotinsky reaction system with global feedback

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·2000
Same journal

Chagas Disease: An Opportunistic Infection in AIDS.

Current infectious disease reports·2026
Same journal

Area-based Deprivation Indices and Healthcare-Associated Infections: A Narrative Review of Evidence.

Current infectious disease reports·2025
Same journal

Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays.

Current infectious disease reports·2024
Same journal

To Tweet or Not to Tweet-a Review of the Viral Power of Twitter for Infectious Diseases.

Current infectious disease reports·2024
Same journal

Web alert.

Current infectious disease reports·2024
Same journal

Bacterial Vaginosis in Postmenopausal Women.

Current infectious disease reports·2023
See all related articles

Hepatitis C virus (HCV) infection impacts millions, often leading to liver failure. While effective treatments exist for some, their benefits in immunocompromised patients, including those with HIV or post-transplant, require further study.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV) infection is a significant public health issue in the United States, affecting over 4 million individuals.
  • HCV is a primary cause of liver failure, frequently necessitating liver transplantation.
  • Effective combination therapies are available for specific patient groups at risk of cirrhosis progression.

Purpose of the Study:

  • To evaluate the established benefits of Hepatitis C virus therapies.
  • To investigate the less-established benefits of these therapies in immunosuppressed patient populations.
  • To identify knowledge gaps regarding HCV treatment efficacy in HIV-infected patients and liver transplant recipients.

Main Methods:

  • Literature review of existing Hepatitis C virus treatment guidelines.

Related Experiment Videos

  • Analysis of clinical trial data focusing on specific patient subgroups.
  • Comparative analysis of treatment outcomes in immunocompetent versus immunosuppressed hosts.

    • Main Results:

    • Established efficacy of current combination therapies for preventing cirrhosis in at-risk populations.
    • Limited data and less certainty regarding the benefits of these therapies in immunosuppressed individuals.
    • Specific challenges in treating Hepatitis C virus in HIV-infected patients and liver transplant recipients.

    Conclusions:

    • Current Hepatitis C virus therapies offer significant benefits for preventing cirrhosis in defined patient groups.
    • Further research is crucial to establish the safety and efficacy of these treatments in immunosuppressed populations.
    • Optimizing Hepatitis C virus management in complex patient scenarios, such as HIV coinfection and post-transplant settings, remains an important clinical challenge.